Search Results - "Olariu, Eva"

An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer by Stringer-Reasor, Erica M, May, Jori E, Olariu, Eva, Caterinicchia, Valerie, Li, Yufeng, Chen, Dongquan, Della Manna, Deborah L, Rocque, Gabrielle B, Vaklavas, Christos, Falkson, Carla I, Nabell, Lisle M, Acosta, Edward P, Forero-Torres, Andres, Yang, Eddy S

“…Poly (ADP-ribose)-polymerase inhibitors (PARPi) have been approved for cancer patients with germline BRCA1/2 (gBRCA1/2) mutations, and efforts to expand the…”
Get full text

Carcinoid Syndrome: A Review by Gade, Ajay K, Olariu, Eva, Douthit, Nathan T

“…Carcinoid syndrome (CS) is a paraneoplastic syndrome caused by the release of serotonin and other substances from well-differentiated neuroendocrine tumors…”
Get full text

Abstract PS10-30: An open label, pilot study of veliparib and lapatinib in patients with metastatic, triple negative breast cancer by Stringer-Reasor, Erica M, May, Jori E, Olariu, Eva, Caterinicchia, Valeria, Li, Yufeng, Manna, Deborah Della, Rocque, Gabrielle B, Vaklavas, Christos, Falkson, Carla I, Nabell, Lisle M, Acosta, Edward P, Forero-Torres, Andres, Yang, Eddy S

“…Abstract Purpose: Poly (ADP-ribose)-polymerase inhibitors (PARPi) have been approved for cancer patients with germline BRCA1/2(gBRCA1/2) mutations, and efforts…”
Get full text